Biggest News Aggregation in the World
📰 Ziping Wei News

Ziping Wei News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ziping Wei. Real-time updates on events, politics, business and more.

BLISS BIOPHARMACEUTICAL ENTERS INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WITH AN OPTION OF STRATEGIC COLLABORATION WITH EISAI FOR BB-1701

/PRNewswire/ -- Bliss Biopharmaceutical (Hangzhou) Co., Ltd, ("BlissBio") a clinical-stage biopharmaceutical company developing differentiated antibody-drug...
Ziping Wei Prnewswire Bliss Biopharmaceutical Hangzhou Co Ltd Eisai Co Ltd United Nations Sustainable Development Goals Sdgs Bliss Biopharmaceutical Hangzhou Co Ltd Co Ltd

Eisai Strikes Cancer Alliance to Line Up Potential Challenger to AstraZeneca Drug

Eisai gains an option to license a Bliss Biopharmaceutical drug that targets HER2, a cancer protein that has become a hot target for addressing several types of solid tumors. BlissBio could receive up to $2 billion in milestones and other payments.
United States Daiichi Sankyo Ziping Wei American Society Of Clinical Oncology Bristol Myers Squibb American Association For Cancer Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science